Entergy Texas, Inc. financials

ETI-P CIK 0001427437

Source: EDGAR filings · Built 2026-09-24T00:43:12Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept Q2 2026Q2 2026Q2 2026Q2 2026
Free Cash Flow -2.31B — — -1.87B
EBITDA 1.46B — — 1.42B
Working Capital -794.39M — -2.02B —
Net Debt 30.77B — 29.01B —
Operating Margin 24.13% — — 25.16%
Net Margin 13.84% — — 14.18%
Return on Equity (ROE) 2.68% 2.24% — 2.89%
Return on Assets (ROA) 0.62% — — —
Current Ratio 0.91× — 0.74× —
Debt-to-Equity 1.90× — 1.83× —
Effective Tax Rate 21.26% — — 22.68%
Cash Conversion Ratio 5.58× — — 3.81×
Accruals Ratio -0.03× — — —
CapEx Coverage 0.54× — — 0.49×
Free Cash Flow Per Share $-4.95 — — $-4.20

Income Statement

Concept Q2 2026Q2 2026Q2 2026Q2 2026
Revenues 3.52B — — 3.33B
Operating Income Loss 850.09M — — 837.42M
Income Tax Expense Benefit 131.68M — — 138.40M
Earnings Per Share Basic $1.05 — — $1.07
Weighted Average Number Of Shares Outstanding Basic 458.75M — — 439.18M
Earnings Per Share Diluted $1.03 — — $1.05
Weighted Average Number Of Diluted Shares Outstanding 466.31M — — 445.70M

Balance Sheet

Concept Q2 2026Q2 2026Q2 2026Q2 2026
Cash And Cash Equivalents At Carrying Value 3.85B — 1.93B —
Assets Current 8.20B — 5.81B —
Assets 79.00B — 71.89B —
Long Term Debt 33.06B — 30.28B —
Liabilities Current 9.00B — 7.82B —
Long Term Debt Noncurrent 31.55B — 27.90B —
Stockholders Equity 18.23B — 16.92B —

Cash Flow Statement

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ETI-P CIK 0001427437), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

Read from the filing itself: Q2 2026 (10-Q filed 2026-07-31) . SEC's company-facts API had not yet incorporated this filing when this page was built, so its facts were taken directly from the filing's own XBRL instance document on EDGAR — the same as-tagged values the API publishes once it catches up.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

IMUX

Immunic, Inc.

SCCO

SOUTHERN COPPER CORP/

BIOE

BIO ESSENCE CORP.